John Wiley (WLY) Director Grant Increases Beneficial Ownership to 41,142 Shares
Rhea-AI Filing Summary
John Wiley & Sons, Inc. (WLY) director Mari Jean Baker was granted 3,275 phantom stock units on 09/25/2025 as her annual director stock award under the 2022 Omnibus Stock and Long-Term Incentive Plan and deferred under the Director Deferred Compensation Plan. The phantom units convert 1-for-1 into Class A common stock and are reported at an aggregate post-transaction beneficial ownership of 41,142 shares. The units vest on the earliest of the day before the next annual meeting, the director's death or disability, or a change in control, and will settle in Class A common stock upon separation from the Board. The award price per share is shown as $39.69.
Positive
- 3,275 phantom stock units granted to align the directors interests with shareholders
- Deferral under the Director Deferred Compensation Plan preserves company cash and ties compensation to long-term equity performance
- Vesting conditions (next annual meeting, death/disability, change in control) restrict immediate monetization
Negative
- None.
Insights
TL;DR: A routine, equity-based director award increases insider alignment with shareholders without immediate dilution.
The grant of 3,275 phantom stock units is a standard annual director compensation practice that ties a directors economic interests to long-term shareholder value. Vesting tied to the next annual meeting, death/disability, or change in control is typical and limits immediate transferability. Settlement in Class A shares on separation means the company will issue or transfer underlying shares later, which could have modest dilutive impact depending on total outstanding shares.
TL;DR: Director deferral into phantom units preserves cash and aligns compensation with equity performance.
Deferral under the Director Deferred Compensation Plan indicates the director elected to receive equity-based pay later, which conserves company cash and aligns incentives. The reported per-share figure of $39.69 likely represents the grant valuation reference. The resulting 41,142 beneficially owned shares provide context on the directors existing stake, but the single grant size appears modest relative to typical company share counts.